{"public_id":"cl_27a4490ed666ae6d6469be291df227d9","status":"active","superseded_by_public_id":null,"corpus_id":25350561,"text":"Neutralizing antigenicity differs greatly between the existing vaccine strains and feline calicivirus strains prevalent in Japan.","confidence":0.94,"paper":{"corpus_id":25350561,"title":"Neutralizing feature of commercially available feline calicivirus (FCV) vaccine immune sera against FCV field isolates.","url":"https://sah.borca.ai/papers/25350561"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.94,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_2979184968e4cf1c4bc76f2ca19f86bd","name":"feline calicivirus strains prevalent in Japan","description":"Circulating feline calicivirus strains sampled from the Japanese population of infected cats.","types":["viral strains"],"url":"https://sah.borca.ai/concepts/co_2979184968e4cf1c4bc76f2ca19f86bd"},{"public_id":"co_735f8b3565d22d3ba0080e29dd6e662d","name":"existing vaccine strains","description":"The virus strains used in the currently available feline calicivirus vaccines.","types":["viral strains"],"url":"https://sah.borca.ai/concepts/co_735f8b3565d22d3ba0080e29dd6e662d"},{"public_id":"co_e4a0b489460ff6675fd8452f59273c80","name":"neutralizing antigenicity","description":"The capacity of a virus strain to be recognized and neutralized by vaccine-induced antibodies.","types":["immunological property"],"url":"https://sah.borca.ai/concepts/co_e4a0b489460ff6675fd8452f59273c80"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_27a4490ed666ae6d6469be291df227d9"}